Neurobiology, Neurodegeneration & Repair Laboratory, National Eye Institute, Bethesda, Maryland, United States of America.
PLoS One. 2012;7(9):e42446. doi: 10.1371/journal.pone.0042446. Epub 2012 Sep 11.
Humans with Hermansky-Pudlak Syndrome (HPS) or ocular albinism (OA1) display abnormal aspects of organelle biogenesis. The multigenic disorder HPS displays broad defects in biogenesis of lysosome-related organelles including melanosomes, platelet dense granules, and lysosomes. A phenotype of ocular pigmentation in OA1 is a smaller number of macromelanosomes, in contrast to HPS, where in many cases the melanosomes are smaller than normal. In these studies we define the role of the Mreg(dsu) gene, which suppresses the coat color dilution of Myo5a, melanophilin, and Rab27a mutant mice in maintaining melanosome size and distribution. We show that the product of the Mreg(dsu) locus, melanoregulin (MREG), interacts both with members of the HPS BLOC-2 complex and with Oa1 in regulating melanosome size. Loss of MREG function facilitates increase in the size of micromelanosomes in the choroid of the HPS BLOC-2 mutants ruby, ruby2, and cocoa, while a transgenic mouse overexpressing melanoregulin corrects the size of retinal pigment epithelium (RPE) macromelanosomes in Oa1(ko/ko) mice. Collectively, these results suggest that MREG levels regulate pigment incorporation into melanosomes. Immunohistochemical analysis localizes melanoregulin not to melanosomes, but to small vesicles in the cytoplasm of the RPE, consistent with a role for this protein in regulating membrane interactions during melanosome biogenesis. These results provide the first link between the BLOC pathway and Oa1 in melanosome biogenesis, thus supporting the hypothesis that intracellular G-protein coupled receptors may be involved in the biogenesis of other organelles. Furthermore these studies provide the foundation for therapeutic approaches to correct the pigment defects in the RPE of HPS and OA1.
患有 Hermansky-Pudlak 综合征(HPS)或眼白化病(OA1)的人类表现出细胞器生物发生的异常方面。多基因疾病 HPS 在溶酶体相关细胞器的生物发生中显示出广泛的缺陷,包括黑素体、血小板致密颗粒和溶酶体。OA1 的眼部色素沉着表型是大黑素体数量较少,而 HPS 中许多情况下黑素体比正常小。在这些研究中,我们定义了 Mreg(dsu)基因的作用,该基因抑制 Myo5a、黑色素蛋白和 Rab27a 突变小鼠的毛色稀释,维持黑素体大小和分布。我们表明,Mreg(dsu)基因座的产物,黑色素调节蛋白(MREG),与 HPS BLOC-2 复合物的成员和 Oa1 相互作用,调节黑素体大小。MREG 功能丧失会促进 HPS BLOC-2 突变体红宝石、红宝石 2 和可可的脉络膜中小黑素体的大小增加,而过表达黑色素调节蛋白的转基因小鼠可纠正 Oa1(ko/ko)小鼠中视网膜色素上皮 (RPE) 大黑素体的大小。总的来说,这些结果表明 MREG 水平调节黑色素体的黑色素掺入。免疫组织化学分析将黑色素调节蛋白定位在黑素体上,而是在 RPE 的细胞质中的小泡中,这与该蛋白在调节黑素体生物发生过程中的膜相互作用的作用一致。这些结果首次将 BLOC 途径与 Oa1 在黑素体生物发生中联系起来,从而支持细胞内 G 蛋白偶联受体可能参与其他细胞器生物发生的假说。此外,这些研究为治疗方法提供了基础,可以纠正 HPS 和 OA1 的 RPE 中的色素缺陷。